FIFVX
Price
$25.27
Change
+$0.10 (+0.40%)
Updated
Jul 25 closing price
Net Assets
203.82M
VIGRX
Price
$233.81
Change
+$1.03 (+0.44%)
Updated
Jul 25 closing price
Net Assets
311.95B
Interact to see
Advertisement

FIFVX vs VIGRX

Header iconFIFVX vs VIGRX Comparison
Open Charts FIFVX vs VIGRXBanner chart's image
Fidelity Advisor Founders I
Price$25.27
Change+$0.10 (+0.40%)
VolumeN/A
Net Assets203.82M
Vanguard Growth Index Investor
Price$233.81
Change+$1.03 (+0.44%)
VolumeN/A
Net Assets311.95B
FIFVX vs VIGRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FIFVX vs. VIGRX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIFVX is a Buy and VIGRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 312B vs. FIFVX (204M). VIGRX pays higher dividends than FIFVX: VIGRX (0.34) vs FIFVX (0.00). FIFVX was incepted earlier than VIGRX: FIFVX (6 years) vs VIGRX (33 years). FIFVX (0.75) is less costly to investors than VIGRX (0.17). FIFVX is a more actively managed with annual turnover of: 41.00 vs. VIGRX (11.00). FIFVX has a lower initial minimum investment than VIGRX: FIFVX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 26.62 vs. FIFVX (19.65). VIGRX return over 5 years is better than : 116.11 vs. FIFVX (79.98).
FIFVXVIGRXFIFVX / VIGRX
Total Expense Ratio0.750.17441%
Annual Report Gross Expense Ratio0.750.17441%
Fund Existence6 years33 years-
Gain YTD8.13010.65876%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets204M312B0%
Annual Yield % from dividends0.000.34-
Returns for 1 year19.6526.6274%
Returns for 3 years78.0094.3883%
Returns for 5 years79.98116.1169%
Returns for 10 yearsN/A314.90-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDV17.140.33
+1.96%
Indivior PLC
ALNT39.740.46
+1.17%
Allient
RF26.420.12
+0.46%
Regions Financial Corp
IBIO0.73-0.01
-0.88%
iBio
IKT1.77-0.08
-4.32%
Inhibikase Therapeutics